PT-141

PT-141 10 mg is a synthetic cyclic peptide research material commonly identified as Bremelanotide. Vertex Labs supplies PT-141 as 10 mg of lyophilized research material within a single sealed vial for controlled laboratory evaluation and non-clinical research workflows.

Its defined cyclic peptide structure, molecular characteristics, and labeled fill amount provide clear identifiers for laboratory documentation, material tracking, and research environments where batch consistency, controlled handling, and accurate compound identification are required.

Product Specifications

Research Material Identification

PT-141 is identified by its defined cyclic peptide sequence, Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-OH, associated molecular characteristics, and labeled 10 mg fill amount. These identifiers help distinguish the material from other synthetic peptide research compounds and support accurate documentation within controlled laboratory environments.

Researchers should verify the 10 mg strength, vial labeling, batch number, sequence information, and corresponding analytical documentation before use. Maintaining clear material identification and batch traceability supports consistency across laboratory workflows.

Quality & Documentation

Each PT-141 10 mg batch released by Vertex Labs is supported by batch-level documentation and Certificate of Analysis availability following quality review. Documentation may include identity confirmation, purity assessment, active weight verification, labeling review, and other analytical information relevant to the specific research batch.

Review available batch documentation through the
Vertex Labs COA database.
Additional information regarding laboratory review procedures, documentation standards, and quality controls is available on our
Testing Standards page.

Handling & Storage

PT-141 10 mg should be handled using established laboratory practices and appropriate internal quality procedures. Personnel should review the labeled strength, product labeling, batch-specific documentation, container condition, and applicable storage requirements before use in a controlled laboratory environment.

Keep the vial sealed until required for laboratory preparation and store the material according to the conditions specified on the product label. Laboratories should maintain appropriate handling, documentation, and material-control procedures for their research environment.